menu search

INFI / MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates

MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates
SAN DIEGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--MEI Pharma, Inc. (Nasdaq: MEIP) (“MEI”), a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, and Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity”), a clinical-stage biotechnology company developing eganelisib, a first-in-class, oral, immuno-oncology macrophage reprogramming drug candidate, announced today that the companies will host a recorded joint video webcast that will be available at 8:00 am Eastern. Read More
Posted: Jun 15 2023, 12:08
Author Name: Business Wire
Views: 102132

INFI News  

Why Is Infinity Pharmaceuticals (INFI) Stock Up 84% Today?

By InvestorPlace
August 8, 2023

Why Is Infinity Pharmaceuticals (INFI) Stock Up 84% Today?

Infinity Pharmaceuticals (NASDAQ: INFI ) stock is rocketing higher on Tuesday morning despite a lack of news from the biopharmaceutical company. Inve more_horizontal

MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates

By Business Wire
June 15, 2023

MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates

SAN DIEGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--MEI Pharma, Inc. (Nasdaq: MEIP) (“MEI”), a clinical-stage pharmaceutical company focused on advanci more_horizontal

Will Infinity Pharmaceuticals (INFI) Report Negative Q4 Earnings? What You Should Know

By Zacks Investment Research
March 28, 2023

Will Infinity Pharmaceuticals (INFI) Report Negative Q4 Earnings? What You Should Know

Infinity (INFI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with more_horizontal

Down 44.4% in 4 Weeks, Here's Why Infinity (INFI) Looks Ripe for a Turnaround

By Zacks Investment Research
November 17, 2022

Down 44.4% in 4 Weeks, Here's Why Infinity (INFI) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for Infinity (INFI) as it is technically in oversold territory now. In addition to this technical meas more_horizontal

Infinity Pharmaceuticals, Inc. (INFI) Q3 2022 Earnings Call Transcript

By Seeking Alpha
November 14, 2022

Infinity Pharmaceuticals, Inc. (INFI) Q3 2022 Earnings Call Transcript

Infinity Pharmaceuticals, Inc. (NASDAQ:INFI ) Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET Company Participants Jayne Kauffman - Seni more_horizontal

Infinity Pharmaceuticals, Inc. (INFI) CEO Adelene Perkins on Q2 2022 Results - Earnings Call Transcript

By Seeking Alpha
August 9, 2022

Infinity Pharmaceuticals, Inc. (INFI) CEO Adelene Perkins on Q2 2022 Results - Earnings Call Transcript

Start Time: 16:30 January 1, 0000 4:58 PM ET Infinity Pharmaceuticals, Inc. (NASDAQ:INFI ) Q2 2022 Earnings Conference Call August 09, 2022, 16:30 PM more_horizontal

Infinity Pharmaceuticals, Inc. (INFI) CEO Adelene Perkins on Q1 2022 Results - Earnings Call Transcript

By Seeking Alpha
May 3, 2022

Infinity Pharmaceuticals, Inc. (INFI) CEO Adelene Perkins on Q1 2022 Results - Earnings Call Transcript

Infinity Pharmaceuticals, Inc. (NASDAQ:INFI ) Q1 2022 Earnings Conference Call May 3, 2022 4:30 AM ET Company Participants Jayne Kauffman - Senior Exe more_horizontal


Search within

Pages Search Results: